Rotavirus Vaccine — A Powerful Tool to Combat Deaths from Diarrhea

Author:
  • MSMathuram Santosham
    Mathuram Santosham

Abstract
Rotavirus infection, the leading cause of severe childhood diarrhea in both developed and developing countries, results in over half a million deaths each year.1 Currently, two rotavirus vaccines (Rotarix [GlaxoSmithKline Biologicals] and RotaTeq [Merck]) are licensed in many countries and used routinely in several. Until recently, available efficacy data were from developed and developing countries with relatively low mortality rates among children younger than 5 years of age.

This publication has 8 references indexed in Scilit: